 | 26 October 2007
UVIG welcomes HPV vaccine programme
UVIG welcomes today’s announcement by the DH to introduce a national HPV immunisation programme to vaccinate girls aged 12 – 13 years of age against cervical cancer, starting from September 2008, together with a 2 year catch up programme from 2009.
This demonstrates the value of vaccines and their role in preventing serious disease. We welcome the Government’s decision to focus on the prevention of ill health and the move from a sickness service to a wellbeing service. Vaccines have, and will continue to have, an important role in the strategy against infectious diseases.
|
| 30 August 2007
A Third of the UK doesn’t understand importance of vaccination
Medical experts and Tony Robinson launch campaign for better understanding of the value of immunisation to prevent diseases like typhoid becoming more common in Britain
UVIG
|
| 8 March 2007
Department of Health publishes seasonal flu programme review
UVIG notes today’s publication of Review of the arrangements for the Seasonal Influenza Programme.
UVIG
|
| 23 November 2006
UVIG Statement: Pulse Survey Results
The UK Vaccines Industry Group (UVIG) recognises the importance of the seasonal flu vaccine as a public health initiative and, as part of this, the importance of communication about the delivery of supply.
UVIG
|
| 1 August 2006
Flu vaccine manufacturers confirm quantities for winter 2006
The UK Vaccine Industry Group (UVIG) is pleased to confirm that the volume of flu vaccine available for 2006/07 will total more than 15 million doses.
This volume of vaccine meets the estimates indicated by the Department of Health in March as being required to successfully implement the UK vaccination programme.
In June, UVIG advised UK governments and public health officials, customers and the media that a delay of the 2006 seasonal flu vaccine was anticipated due to the difficulties in growing one of the strains, recommended by the World Health Organisation, for the vaccine. A number of measures were put in place and a longer production period has made good the initial shortfall.
Chairman of UVIG, Paul Rayner said “The bulk of the vaccine will arrive in October and November, and manufacturers will contact GP practices during August with details of delivery schedules so that flu clinics can be organised appropriately.”
Mr Rayner said that UVIG appreciates the co-operation it is receiving from all public health authorities and GPs and their staff in dealing with the delay in supply. UVIG supports fully the Chief Medical Officers’ letters to GPs and guidance to prioritise those people in at-risk groups.
The annual influenza campaign is an important public health initiative and UVIG continues to work closely with relevant authorities throughout the UK.
UVIG
|
| 28 June 2006
FLU VACCINE SUPPLY FOR THE 2006/07 SEASON
UVIG
|
| 13 March 2006
UVIG response to House of Lords debate on report published by Science and Technology Select Committee on pandemic influenza
The House of Lords Science and Technology Select Committee published its report on Pandemic Influenza on 16 December 2005. UVIG welcomes the publication of this report and the subsequent debate in the House of Lords on 20 January 2006.
UVIG
|
| 9 March 2006
UK government builds stockpile of vaccine against H5N1 pandemic flu strain
The UK Government has purchased 3.5 million doses of a vaccine against the H5N1 strain of bird flu for the vaccination of healthcare workers in the event of a pandemic. On 24 February, it awarded two contracts to Chiron Corporation and Baxter Healthcare Corporation.
UVIG
|
| 6 March 2006
WHO announces composition of flu vaccines for 2006-2007
The World Health Organization has recently issued its recommendations for the composition of influenza virus vaccines for use in the 2006-2007 northern hemisphere influenza season (winter).
UVIG
|
| 17 February 2006
Government responds to the House of Lords Science and Technology Committee's Report on pandemic influenza
The Government has issued a formal, written response to a report published by the House of Lords Science and Technology Committee on pandemic influenza. The response follows a debate in the House of Lords on 20 January 2006.
UVIG
|
| 9 February 2006
UVIG welcomes the decision by the Department of Health to include a vaccine against pneumococcal disease and a Hib and Men C booster vaccine in the Paediatric Immunisation Schedule
On Wednesday, 8 February, the Department of Health announced its decision to include a vaccine against pneumococcal disease and a booster vaccination against Haemophilus influenzae type b (Hib) and Meningitis C (MenC) in the UK national paediatric immunisation schedule.
UVIG
|
| 9 February 2006
Department of Health announces changes to the paediatric immunisation schedule
UVIG welcomes the decision by the Department of Health to include a vaccine against pneumococcal disease and a Hib and MenC booster vaccination in the paediatric immunisation schedule
UVIG
|
| 20 October 2005
UVIG’s response to the revised UK Influenza Pandemic Contingency Plan
The UK Vaccine Industry Group welcomes the publication of the UK Health Departments’ revised pandemic preparedness plan which identifies vaccines as being fundamental in preparing for a potential influenza pandemic:
UVIG
|
| 3 August 2005
JCVI recommends review into lowering age to 50 years for flu vaccine
The UK Vaccine Industry Group supports the recommendation from the JCVI influenza subgroup to review the benefits of lowering the age from 65 to 50 years for routine flu vaccination.
UVIG
|
| 3 August 2005
Government plans to purchase 2 million doses of Avian Flu vaccine
The UK Vaccine Industry Group (UVIG) welcomes the recent announcement to purchase Avian Flu vaccines as a strategic stockpile for use with priority groups in the first instance.
|
| 26 July 2005
Influenza vaccine supply 2005/6
Supply assured for influenza vaccines 2005/06 season – some delivery delays expected.
UVIG
|
| 2 June 2005
UVIG calls for Government to invest now to meet pandemic flu needs
The UK Vaccine Industry Group today urged the Government to invest in securing sufficient quantities of flu vaccines in order to meet its stated goal of protecting the British public in the event of a pandemic influenza outbreak.
UVIG
|
| 1 March 2005
Flu pandemic preparedness
Vaccines offer best line of defence to protect the UK population.
UVIG
|
